OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41.
Published August 6, 2014 · Recall initiated: July 28, 2014
Summary
FDA records drug Class III recall D-1486-2014, published August 6, 2014 and initiated July 28, 2014. Recalling firm: Boehringer Ingelheim Roxane Inc; Status: Terminated; Reported quantity: 2,149 Bottles; Lot: Lot #: 360241A, Expiry: 05/2015. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications: Out of specification result for preservative sodium benzoate.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boehringer Ingelheim Roxane Inc
- Distributor
- U.S. Nationwide
- Lot
- Lot #: 360241A, Expiry: 05/2015.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by RoerigAugust 6, 2014
- FDADermamedics Post Procedure Cream, 1 ounce containers which were distributed with a SKU number of DM 1026August 6, 2014
- FDACalcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDCJuly 16, 2014
- FDAAzathioprine Tablets USP, 50 mg, 100 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216,May 14, 2014
- FDAMercaptopurine Tablets USP, 50 mg, 25 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio,May 14, 2014
- FDASpiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use WithApril 16, 2014
Questions about this recall
Was OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41. recalled?
Yes. FDA published recall D-1486-2014 on August 6, 2014. Reported hazard: Failed Stability Specifications: Out of specification result for preservative sodium benzoate.
What should I do if I have this product?
Voluntary: Firm initiated · Letter